BME vs IVV

BME vs IVV

Which is better, BME or IVV?

Large Cap Value against Large Cap Blend.

IVV has a lower expense ratio. BME led over 1Y, IVV over 3Y, 5Y and the full window. IVV is less concentrated, with 37.8% of the fund in its ten largest positions against 51.5%.

Lower Fees: IVVHigher Returns: splitLess Concentrated: IVV

MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.

Side-by-Side Comparison

MetricBMEIVV
Expense Ratio1.14%0.03%Best
AUM$602M$876.4B
Dividend Yield6.78%1.06%
Holdings159508
YTD Return+15.57%Best+13.23%
1Y Return+33.15%Best+17.38%
3Y Return (annualized)+12.66%+22.67%Best
5Y Return (annualized)+5.57%+13.13%Best
Volatility (annualized)17.1%14.9%Best
Max Drawdown-44.6%Best-56.5%
$10,000 over 5 years$13,113$18,531Best
Top 10 Weight51.5%37.8%Best
Fund FamilyBlackRock, Inc. (US)iShares by BlackRock (US)
CategoryEquityEquity
StyleLarge Cap ValueLarge Cap Blend
InceptionMar 31, 2005May 15, 2000

Volatility and max drawdown are measured over the window both funds cover: Mar 29, 2005 to Sep 24, 2026 (21.5 years).

BME vs IVV growth

Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 21.5 years both funds cover.

BME vs IVV Performance

BlackRock Health Sciences Trust (BME) is an ETF from BlackRock, Inc. (US) and iShares Core S&P 500 ETF (IVV) is an ETF from iShares by BlackRock (US). Over the past year BME returned +33.15% while IVV returned +17.38%. Year to date, BME is up 15.57% versus a gain of 13.23% for IVV.

Over three years, BME compounded at +12.66% per year against +22.67% for IVV; over five years the annualized figures are +5.57% and +13.13% respectively. Across the full 22-year window we track, IVV has the edge at +9.59% annualized vs +4.57%.

Past performance does not guarantee future results.

Risk: Volatility and Drawdowns

BME has been the more volatile fund, with annualized monthly volatility of 17.1% compared with 14.9% for IVV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.

The deepest peak-to-trough decline in our data was -44.6% for BME and -56.5% for IVV. Drawdown depth is what each fund did in the worst stretch of the window measured above.

The two funds' monthly returns correlate at 0.66. They move together some of the time, and apart the rest.

Fees and Cost Over Time

BME charges 1.14% per year while IVV charges 0.03%. On a $10,000 position that is $114 vs $3 annually, a gap of $111 per year that compounds over a long holding period. On income, BME currently yields 6.78% against 1.06% for IVV.

Holdings Overlap

BME already in IVV68.6%
IVV already in BME8.1%

68.6% of BME's money is in holdings IVV also owns. 8.1% of IVV's money is in holdings BME also owns.

The two portfolios partly overlap.

The two holdings books were reported 62 days apart, BME as of Jun 30, 2026 and IVV as of Aug 31, 2026, so some of the difference between them is the time between the two reports rather than the funds.

35 positions in common, counted across the 133 positions we hold weights for in BME and 490 in IVV, against full books of 159 and 508.

What only one of them owns

Our book lists 448 positions for IVV that do not appear in our book for BME (90.6% of the fund), and 80 for BME that do not appear in IVV (21.3%).

Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.

Top Shared Holdings

StockWeight in BMEWeight in IVVDifference
LLYEli Lilly & Co.12.46%1.38%11.08%
JNJJohnson & Johnson - Common7.80%0.97%6.83%
UNHUnitedhealth Group Incorporated6.12%0.53%5.59%
MRKMerck & Company Inc5.23%0.55%4.68%
ABBVAbbvie Inc.5.07%0.68%4.39%
AMGNAmgen Inc.3.37%0.35%3.02%
TMOThermo Fisherscientific Inc.2.97%0.35%2.62%
VRTXNvaesrtex Pharmaceuticals Inc2.78%0.21%2.57%
EWEdwards Lifesciences Corp2.37%0.08%2.29%
ABTAbbott Laboratories1.90%0.29%1.61%

68.6% of BME is already inside IVV.

You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.

BMEIVV

Free for up to 10 holdings. No account needed.

Frequently Asked Questions

Which is cheaper, BME or IVV?

BME has an expense ratio of 1.14% while IVV charges 0.03%. IVV is the cheaper option, by $111 a year on a $10,000 investment.

Which performed better, BME or IVV?

Over the past year BME returned +33.15% vs +17.38% for IVV, so BME leads on 1-year performance. Over the longest common window we track (22 years), BME annualized +4.57% vs +9.59% for IVV. Past performance does not guarantee future results. This is information, not a recommendation.

Which is riskier, BME or IVV?

BME has been the more volatile fund at 17.1% annualized versus 14.9% for IVV. Worst drawdown: BME -44.6% vs IVV -56.5%.

Should I hold both BME and IVV?

BME and IVV have a monthly-return correlation of 0.66, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.

What is the holdings overlap between BME and IVV?

68.6% of BME's money is in holdings IVV also owns. 8.1% of IVV's is in holdings BME also owns. They hold 35 positions in common, counted across the 133 positions we hold weights for in BME and 490 in IVV.

Which pays a higher dividend, BME or IVV?

BME yields 6.78% while IVV yields 1.06%, so BME currently pays the higher dividend yield.

Is IVV better than BME?

IVV has a lower expense ratio. BME led over 1Y, IVV over 3Y, 5Y and the full window. IVV is less concentrated, with 37.8% of the fund in its ten largest positions against 51.5%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.